| Acquired by | Medtronic |
| Date | 7/11 |
| Website | salientsurgical.com |
| Category | BioTech |
| Phone | 603-742-1515 |
| Employees | |
| Founded | 1999 |
| TOTAL | $15M |
| FUNDING TOTAL | $15M |
| Venture Round, 1/10 Medtronic Arnerich Massena & Associates RiverVest | $15M |
Established in 1999, Salient Surgical Technologies, Inc. is a global, privately held medical technology company that develops and markets advanced energy devices used in surgical procedures. Salient’s first line of products were monopolar electrosurgical devices used for the treatment of liver cancers. Today, the company’s bipolar AQUAMANTYS® System is used across a wide range of surgical procedures including orthopaedic reconstruction, spine surgery, orthopaedic trauma, and surgical oncology. Comprised of a bipolar electrosurgical generator & pump system and a portfolio of handheld disposable device, the AQUAMANTYS system uses patented TRANSCOLLATION® technology to haemostatically seal soft tissue and bone, enabling surgeons to reduce and prevent surgical blood loss.
Salient’s products are sold throughout the United States, Europe, and Asia, providing clinical and economic benefits to hospitals, healthcare providers, and patients all over the world. To date, more than 500,000 patients have been treated with TRANSCOLLATION technology.
